Lenvaxen, Lenvatinib

Lenvaxen is used as a targeted therapy drug which is used for the treatment of metastatic and progressive thyroid cancer.

Lenvaxen works to bind to tyrosine kinase receptors and it inhibits vascular epidermal growth factor receptors (VEGFR), VEGFR then inhibits other kinase receptors which have an effect on angiognesis, tumor growth and cancer progression. By binding to VEGFR receptors  Lenvaxen works to block the  pathways that promote cell division

Some of the side effects related with taking Lenvaxen are as below

High blood pressure
Headache
Oral pain
Cough
Swelling
Rash
Taste changes
Dry mouth
Diarrhea
Fatigue
Vomiting
Abdominal pain
Joint/muscle aches
Decreased appetite
Weight loss
Nausea
Mouth sores
Dizziness
Heartburn
Hair loss

If you are experiencing a fever of 38 degrees Celsius or higher, experiencing shortness of breath, chest pains or pains in your arms,weakness in one side of the body or sudden vision changes please go to the emergency room immediately. 

Store  Lenvaxen in a cold dry place away from direct sunlight

This product is certified and registered with Directorate General of Drug Administration (DGDA) , Ministry of Health & Family Welfare, Government of the People's republic of Bangladesh.